IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
IAI Accepts, published online ahead of print on 4 August 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
IAI.00660-08v1
76/10/4764    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Wozniak, K. L.
Right arrow Articles by Levitz, S. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wozniak, K. L.
Right arrow Articles by Levitz, S. M.

 Previous Article  |  Next Article 

Infect. Immun. doi:10.1128/IAI.00660-08
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Cryptococcus neoformans enters the endolysosomal pathway of dendritic cells and is killed by lysosomal components

Karen L. Wozniak and Stuart M. Levitz*

Department of Medicine, Division of Infectious Diseases, University of Massachusetts Medical School, Worcester, MA USA

* To whom correspondence should be addressed. Email: Stuart.Levitz{at}umassmed.edu.


   Abstract

Cryptococcus neoformans is an opportunistic fungal pathogen that primarily causes disease in immunocompromised individuals. Dendritic cells (DCs) can phagocytose C. neoformans, present cryptococcal antigen, and kill C. neoformans. However, early events following C. neoformans phagocytosis by DCs are not well defined. We hypothesized that C. neoformans traffics to the endosome and the lysosome following phagocytosis by DCs and is eventually killed in the lysosome. Murine bone marrow-derived DCs (BMDCs) or human monocyte-derived DCs (HDCs) were incubated with live encapsulated C. neoformans and opsonizing antibody. Following incubation, DCs were intracellularly stained with antibodies against EEA1 (endosome) and LAMP-1 (late endosome/lysosome). As assessed by confocal microscopy, C. neoformans trafficked to endosomal compartments of DCs within 10 minutes and to lysosomal compartments within 30 minutes post-incubation. In HDCs, studies were repeated using complement-sufficient autologous plasma for opsonization of C. neoformans. These data showed similar results to antibody opsonization, with C. neoformans localized to endosomes within 20 minutes and to lysosomes within 60 minutes post-incubation. Additionally, live real-time imaging studies demonstrated that C. neoformans entered lysosomal compartments within 20 minutes following initiation of phagocytosis. Scanning and transmission electron microscopy demonstrated conventional zipper phagocytosis of C. neoformans by DCs. Finally, lysosomal extracts were purified from BMDCs and incubated with C. neoformans to determine their potential to kill C. neoformans. The extracts killed C. neoformans in a dose-dependent manner. This study shows that C. neoformans enters into endosomal and lysosomal pathways following DC phagocytosis and can be killed by lysosomal components.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2008 by the American Society for Microbiology. All rights reserved.